AbbVie, Gilgamesh Pharmaceuticals Agree to Terms on a Collaboration to Develop Advanced Therapies for Psychiatric Disorders

Posted on by admin

The joint venture aims to address unmet needs in the treatment of mood and anxiety disorders through novel neuroplastogens.

Leave a Reply

Your email address will not be published. Required fields are marked *